| Ytd | -48.43% | |
| 1y | -77.62% |
| Open | 0.48 | Prev Close | 0.47 | Low | 0.46 | High | 0.50 | Mkt Cap | 9.23M |
| Vol | 664.44K | Avg Vol | 14.79M | EPS | -2.52 | P/E | N/A | Forward P/E | -9.08 |
| Beta | 0.97 | Short Ratio | 0.12 | Inst. Own | 22.26% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.35 | 200-d Avg | 0.58 | 1yr Est | 102.00 |
~ ~ The Second Study Fully Enrolled for Breakthrough Therapy-Designated, First-in-Class Opioid Desig
Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's aft
Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.20) per share which beat the anal
Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regu